ERRα and ERRγ coordinate expression of genes associated with Alzheimer's disease, inhibiting DKK1 to suppress tau phosphorylation.
Kaoru SatoKen-Ichi TakayamaYuko SaitoSatoshi InouePublished in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Alzheimer's disease (AD) is a prevalent neurodegenerative disease characterized by cognitive decline and learning/memory impairment associated with neuronal cell loss. Estrogen-related receptor α (ERRα) and ERRγ, which are highly expressed in the brain, have emerged as potential AD regulators, with unelucidated underlying mechanisms. Here, we identified genome-wide binding sites for ERRα and ERRγ in human neuronal cells. They commonly target a subset of genes associated with neurodegenerative diseases, including AD. Notably, Dickkopf-1 (DKK1), a Wnt signaling pathway antagonist, was transcriptionally repressed by both ERRα and ERRγ in human neuronal cells and brain. ERRα and ERRγ repress RNA polymerase II (RNAP II) accessibility at the DKK1 promoter by modulating a specific active histone modification, histone H3 lysine acetylation (H3K9ac), with the potential contribution of their corepressor. This transcriptional repression maintains Wnt signaling activity, preventing tau phosphorylation and promoting a healthy neuronal state in the context of AD.
Keyphrases
- cognitive decline
- signaling pathway
- induced apoptosis
- endothelial cells
- dna methylation
- cerebral ischemia
- genome wide
- transcription factor
- mild cognitive impairment
- cell cycle arrest
- poor prognosis
- stem cells
- gene expression
- pi k akt
- white matter
- cell death
- oxidative stress
- protein kinase
- climate change
- binding protein
- working memory
- resting state
- human health
- mesenchymal stem cells
- subarachnoid hemorrhage